HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 67318551, compound → HCID 11979138, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 67318551 | HCID 67318551 | — |
| Reactant | HCID 86604791 | HCID 86604791 | — |
| Product | HCID 11979138 | HCID 11979138 | 28% |
Reaction Steps
(R)-9-(1-acetylpiperidin-4-yl)-7-amino-6,7,9,10-tetrahydroazepino[3,4-e]indazol-8(3H)-one methanesulfonate (42 mg, 0.08 mmol) and 3-(piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one acetate (30 mg, 0.10 mmol) were reacted in a manner analogous to the preparation of 4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid [8-oxo-9-(2-piperidin-1-yl-ethyl)-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(R)-cyclohepta[e]inden-7-yl]-amide. C18 preparatory HPLC afforded the title compound as white solid in 28% yield. High resolution MS m/e (M+H)+=599.3085.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07384930B2 |
| Source dataset | uspto-grants-2008_06 |
| ORD ID | ord-a6c11a09c9014160a874a6a1b9337744 |
| Source note | uspto-grants-2008_06 |